These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20823770)

  • 1. Correlation of immunohistochemical expression of p53 with unamplified chromosome 17 polysomy in invasive breast carcinoma.
    Krishnamurti U; Zarineh A; Atem FD; Silverman JF
    Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):28-32. PubMed ID: 20823770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma.
    Krishnamurti U; Hammers JL; Atem FD; Storto PD; Silverman JF
    Mod Pathol; 2009 Aug; 22(8):1044-8. PubMed ID: 19396150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification.
    Orsaria M; Khelifa S; Buza N; Kamath A; Hui P
    J Clin Pathol; 2013 Dec; 66(12):1070-5. PubMed ID: 23908451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].
    Zeng X; Liang ZY; Wu SF; Zhou WX; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer.
    Zhu X; Lu Y; Lu H; Yang W; Tu X; Cai X; Zhou X
    Hum Pathol; 2011 Oct; 42(10):1499-504. PubMed ID: 21676436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.
    Vanden Bempt I; Van Loo P; Drijkoningen M; Neven P; Smeets A; Christiaens MR; Paridaens R; De Wolf-Peeters C
    J Clin Oncol; 2008 Oct; 26(30):4869-74. PubMed ID: 18794552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of polysomy-17 on HER2 status and the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.
    Lin CK; Lin WL; Chen FL; Lee MY; Kuo JF; Ruan A; Tyan YS; Chiang H; Chou MC; Han CP
    Int J Gynecol Pathol; 2011 Jul; 30(4):372-9. PubMed ID: 21623202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of HER2 amplification, polysomy 17 and histopathological features of 425 Pakistani breast cancer patients.
    Moatter T; Aban M; Iqbal W; Azam I; Pervaiz A; Siddiqui F; Murad F; Pervez S
    Asian Pac J Cancer Prev; 2011; 12(11):3069-73. PubMed ID: 22393991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
    Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F
    Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic significance of chromosome 17 polysomy in breast cancer].
    Lü YL; Zhong M; Liu L; Wei LX; Zhao P
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):88-91. PubMed ID: 18681318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining true HER2 gene status in breast cancers with polysomy by using alternative chromosome 17 reference genes: implications for anti-HER2 targeted therapy.
    Tse CH; Hwang HC; Goldstein LC; Kandalaft PL; Wiley JC; Kussick SJ; Gown AM
    J Clin Oncol; 2011 Nov; 29(31):4168-74. PubMed ID: 21947821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high copy number of HER2 associated with polysomy 17 on HER2 protein expression in invasive breast carcinoma.
    Shah SS; Wang Y; Tull J; Zhang S
    Diagn Mol Pathol; 2009 Mar; 18(1):30-3. PubMed ID: 19214111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRB7 Expression and Correlation With HER2 Amplification in Invasive Breast Carcinoma.
    Bivin WW; Yergiyev O; Bunker ML; Silverman JF; Krishnamurti U
    Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):553-558. PubMed ID: 26945445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas.
    Stoicănescu D; Andreescu N; Belengeanu A; Meszaros N; Cornianu M
    Rom J Morphol Embryol; 2013; 54(4):1107-13. PubMed ID: 24399009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centromere 17 copy number alteration: negative prognostic factor in invasive breast cancer?
    Petroni S; Addati T; Mattioli E; Caponio MA; Quero C; Rubini V; Giotta F; Simone G
    Arch Pathol Lab Med; 2012 Sep; 136(9):993-1000. PubMed ID: 22938586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
    Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of polysomy 17 on HER-2 gene and protein expression and its clinicopathologic significance in breast cancer].
    Li J; Xu BH; Wang JY; Li Q; Zhang P; Yuan P; Ma F; Fan Y; Cai RG; Li Q
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):84-8. PubMed ID: 23648340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17.
    Torrisi R; Rotmensz N; Bagnardi V; Viale G; Curto BD; Dell'orto P; Veronesi P; Luini A; D'Alessandro C; Cardillo A; Goldhirsch A; Colleoni M
    Eur J Cancer; 2007 Nov; 43(16):2339-44. PubMed ID: 17855075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.